Funded Research

Anne Davidson, MBBS
Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and Feinstein Institutes for Medical Research

The role of the long non-coding RNA lincRNA-Eps in lupus

Katherine Fitzgerald, PhD
University of Massachusetts Medical School

CD244 targeting therapeutics in SLE

Edith Janssen, PhD
Cincinnati Children's Hospital Medical Center

A role for diet-sensitive gut commensals in systemic autoimmunity

Martin Kriegel, MD, PhD
Yale School of Medicine

CD19-targeted cytotoxic T cells for lupus therapy

Marko Radic, PhD
University of Tennessee, Memphis

Tissue sodium in autoimmune disease

Michael Stein, MBChB
Vanderbilt University Medical Center

The OX40L-OX40 axis in lupus pathogenesis

Hideki Ueno, MD, PhD
Mount Sinai School of Medicine

Single cell detection of IFN signaling in lupus patients

Mark Walter, PhD
University of Alabama at Birmingham

2013 Funded Grants

RIG-I regulation of interferon signature in SLE

Ralph Budd, MD
The University of Vermont Medical Center

Mitochondrial autophagy in the control of systemic autoimmunity

Min Chen, PhD
Baylor College of Medicine

Autoantibodies and prolactin participate in a positive feedback loop

Betty Diamond, MD
The Feinstein Institute for Medical Research and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

Cutaneous and systemic lupus induced by UVB

Keith Elkon, MD
University of Washington

Innate immune cell mechanisms controlling inflammation in Systemic Lupus Erythematosus

Hans Haecker, MD PhD
University of Utah, School of Medicine

Mechanisms and consequences of HDL small RNA communication in SLE

Amy Major, PhD
Vanderbilt University Medical Center

TWEAK/Fn14 pathway in the pathogenesis & treatment of neuropsychiatric SLE

Chaim Putterman, MD
Albert Einstein College of Medicine

Function of SLE-related regulatory regions of human A20/TNFAIP3 gene

Gong Shiaoching, PhD
Weill Cornell Medical College

Novel treatments for lupus nephritis

Joshua Thurman, MD
University of Colorado Denver, AMC and DC

Bone marrow stem cell niche dysfunction in human SLE

Lijun Yang, MD
University of Florida

2012 Funded Grants

Biological role of FCRL molecules in SLE pathogenesis

Randall Davis, MD
The University of Alabama at Birmingham

Molecular basis and novel therapy of systemic lupus-associated thrombosis

Bruce Furie, MD
Beth Israel Deaconess Medical Center

Sex hormones, dendritic cells, and the IFN signature in lupus

Stefania Gallucci, MD
Temple University

Hes1 as a novel regulator of the type I interferon pathway in SLE

Xiaoyu Hu, MD, PhD
The Hospital for Special Surgery

Regulation of SLE through SOCS1 mimetic peptides

Joe Larkin, PhD
University of Florida

Exploring the role of interferon kappa in SLE pathogenesis

Deborah Lenschow, MD, PhD
Washington University in St.Louis

Linking ABIN-1 to SLE susceptibility

Averil Ma, MD
The Regents of the University of California, San Francisco

Novel insights into cerebral lupus

Chandra Mohan, MD, PhD
University of Houston

Dual reactive B cells in murine and human SLE

Roberta Pelanda, PhD
University of Colorado Anschutz School of Medicine

Activation of iRhom2/ADAM17/HB-EGF/EGFR pathway in immune complex nephritis

Jane Salmon, MD
The Hospital for Special Surgery

The microbiome and SLE

Gregg Silverman, MD
New York University School of Medicine

Learning from viruses how to suppress type I interferons to cure lupus

Elina Zuniga, PhD
The Regents of the University of California, San Diego